DHR ($232.36) is trading below its intrinsic value of $505.17, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
DHR is poor value based on its earnings relative to its share price (46.75x), compared to the US market average (18.56x)
Valuation
DHR is good value based on its earnings relative to its share price (46.75x), compared to the US Diagnostics & Research industry average (46.83x)
Valuation
1 of 13
DHR News
Valuation
DHR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
46.75x
Industry
46.83x
Market
18.56x
DHR is poor value based on its earnings relative to its share price (46.75x), compared to the US market average (18.56x)
Valuation
DHR is good value based on its earnings relative to its share price (46.75x), compared to the US Diagnostics & Research industry average (46.83x)
Valuation
DHR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.15x
Industry
5.92x
Market
-0.01x
DHR is good value based on its book value relative to its share price (4.15x), compared to the US market average (-0.01x)
Valuation
DHR is good value based on its book value relative to its share price (4.15x), compared to the US Diagnostics & Research industry average (5.92x)
Valuation
DHR price to earnings growth (PEG)
For valuing profitable companies with growth potential
DHR is poor value relative to its rate of earnings growth, measured by PEG ratio (1.72x)
Valuation
DHR's financial health
Profit margin
Revenue
$6.8B
Net Income
$1.2B
Profit Margin
17.7%
DHR's Earnings (EBIT) of $4.77B can safely cover interest payments on company debt ($21.20B)
Financials
DHR's profit margin has decreased (-0.6%) in the last year from (16.4%) to (15.8%)
Financials
Assets to liabilities
Assets
$76.2B
Liabilities
$36.4B
Debt to equity
0.53
DHR's short-term assets ($13.80B) exceed its short-term liabilities ($7.40B)
Financials
DHR's long-term liabilities ($28.98B) exceed its short-term assets ($13.80B)
Financials
DHR's debt relative to shareholder equity (0.92) has decreased or remained constant compared to 5 years ago (1.03)
Financials
DHR's debt to equity ratio (0.92) is considered high
Financials
Cash flow
Operating
$2.2B
Investing
-$581.3M
Financing
-$1.4B
DHR's operating cash flow ($6.21B) is sufficient to service the company's debt ($21.20B)
Financials
Danaher Corp Stock FAQ
What is Danaher Corp's quote symbol?
(NYSE: DHR) Danaher Corp trades on the NYSE under the ticker symbol DHR. Danaher Corp stock quotes can also be displayed as NYSE: DHR.
What is the 52 week high and low for Danaher Corp (NYSE: DHR)?
(NYSE: DHR) Danaher Corp's 52-week high was $248.86, and its 52-week low was $143.01. It is currently -6.63% from its 52-week high and 62.48% from its 52-week low.
How much is Danaher Corp stock worth today?
(NYSE: DHR) Danaher Corp currently has 710,377,467 outstanding shares. With Danaher Corp stock trading at $232.36 per share, the total value of Danaher Corp stock (market capitalization) is $165.06B.
Danaher Corp stock was originally listed at a price of $7.89 in Dec 31, 1997. If you had invested in Danaher Corp stock at $7.89, your return over the last 23 years would have been 2,844.62%, for an annualized return of 15.84%.
How much is Danaher Corp's stock price per share?
(NYSE: DHR) Danaher Corp stock price per share is $232.36 today (as of Apr 9, 2021).
What is Danaher Corp's Market Cap?
(NYSE: DHR) Danaher Corp's market cap is $165.06B, as of Apr 12, 2021.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Danaher Corp's market cap is calculated by multiplying DHR's current stock price of $232.36 by DHR's total outstanding shares of 710,377,467.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.